Global Blood Transfusion Diagnostics Market – Analysis By Product (Kits and Reagents, Instruments), Application (Disease Screening, Blood Grouping), End User, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)
EXECUTIVE SUMMARY
The Global Blood Transfusion Diagnostics Market was valued at USD 2192.55 Million in the year 2020. Rising prevalence of chronic diseases and increasing demand for donor screening are some of the major factors driving the market growth. Rising cases of road accidents, trauma, and surgeries have also led to significant demand for transfusion, thus, driving the market. In addition, there is an increasing risk of Transfusion-Transmitted Infections (TTIs) that has led to high demand for donor screening.
The demand for blood transfusion has experienced an upsurge since the past several years. This is attributed to a large number of patients undergoing surgical procedures for various chronic diseases, such as aplastic anemia, sickle cell anemia and leukemia. This has prompted key players to focus on research & development for advanced instruments, assays and kits in blood banks and hospitals.
The field of Blood Transfusion Diagnostics and blood banking continues to evolve as new infectious agents emerge and as there is increased recognition of non-infectious hazards of transfusion. Increased risk associated with blood transfusion in certain patient population, such as those critically ill or undergoing cardiac surgery has brought a new desire to understand better the beneficial and adverse effects of blood transfusion and of the blood storage lesion, with the continued goal to improve transfusion therapy.
The recent COVID-19 pandemic has presented expansion opportunities for Blood Transfusion Diagnostics market. A series of plasma transfusion trials are being conducted in the United States. Practitioners extract the liquid medium from recovered patients and introduce it to infected ones. This “convalescent plasma” is anticipated to boost the immunity of patients battling the disease.
SCOPE OF THE REPORT
The Global Blood Transfusion Diagnostics Market was valued at USD 2192.55 Million in the year 2020. Rising prevalence of chronic diseases and increasing demand for donor screening are some of the major factors driving the market growth. Rising cases of road accidents, trauma, and surgeries have also led to significant demand for transfusion, thus, driving the market. In addition, there is an increasing risk of Transfusion-Transmitted Infections (TTIs) that has led to high demand for donor screening.
The demand for blood transfusion has experienced an upsurge since the past several years. This is attributed to a large number of patients undergoing surgical procedures for various chronic diseases, such as aplastic anemia, sickle cell anemia and leukemia. This has prompted key players to focus on research & development for advanced instruments, assays and kits in blood banks and hospitals.
The field of Blood Transfusion Diagnostics and blood banking continues to evolve as new infectious agents emerge and as there is increased recognition of non-infectious hazards of transfusion. Increased risk associated with blood transfusion in certain patient population, such as those critically ill or undergoing cardiac surgery has brought a new desire to understand better the beneficial and adverse effects of blood transfusion and of the blood storage lesion, with the continued goal to improve transfusion therapy.
The recent COVID-19 pandemic has presented expansion opportunities for Blood Transfusion Diagnostics market. A series of plasma transfusion trials are being conducted in the United States. Practitioners extract the liquid medium from recovered patients and introduce it to infected ones. This “convalescent plasma” is anticipated to boost the immunity of patients battling the disease.
SCOPE OF THE REPORT
- The report analyses the Blood Transfusion Diagnostics Market by value (USD Million).
- The report analyses the Blood Transfusion Diagnostics Market by Product (Kits & Reagents, Instruments).
- The report analyses the Blood Transfusion Diagnostics Market by Application (Disease Screening, Blood Grouping).
- The report analyses the Blood Transfusion Diagnostics Market by End User (Hospitals, Blood Banks and Others).
- The Global Blood Transfusion Diagnostics Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (United States, Canada, Germany, France, U.K, Italy, China, Japan, India, South Korea).
- The key insights of the report have been presented through the frameworks of the attractiveness of the market and also presented by region, by Streaming Type, Component and by End Users.
- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Bio-Rad Laboratories Inc., F Hoffman-La Roche Ltd., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, Danaher, Hologic Inc., Quest Diagnostics, Promega Corporation, Bio Kit.
- The report presents the analysis of Blood Transfusion Diagnostics Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
- Healthcare and Pharmaceutical Companies
- Transfusion Medicine Companies
- Consulting and Advisory Firms
- Government and Policy Makers
- Regulatory Authorities
1.REPORT SCOPE AND METHODOLOGY
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. BLOOD TRANSFUSION DIAGNOSTICS MARKET: PRODUCT OUTLOOK
4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: SIZING AND FORECAST
4.1 Global Blood Transfusion Diagnostics Market Size, By Value, Year 2016-2026
5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION - BY PRODUCT, BY APPLICATION, BY END USER
5.1 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By Product
5.1.1 Kits & Reagents - Market Size and Forecast (2016-2026)
5.1.2 Instruments - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By Application Type
5.2.1 Disease Screening - Market Size and Forecast (2016-2026)
5.2.2 Blood Grouping - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By End user
5.3.1 Hospitals - Market Size and Forecast (2016-2026)
5.3.2 Blood Banks - Market Size and Forecast (2016-2026)
5.3.3 Others - Market Size and Forecast (2016-2026)
6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Blood Transfusion Diagnostics Market : By Region
7. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET: AN ANALYSIS (2016-2026)
7.1 North America Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.2 North America Blood Transfusion Diagnostics Market - Prominent Companies
7.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
7.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
7.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
7.6 North America Blood Transfusion Diagnostics Market: Country Analysis
7.7 Market Opportunity Chart of North America Blood Transfusion Diagnostics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Blood Transfusion Diagnostics Market : By Country
7.9 United States Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.10 United States Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
7.11 Canada Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET : AN ANALYSIS (2016-2026)
8.1 Europe Blood Transfusion Diagnostics Market : Size and Forecast (2016-2026), By Value
8.2 Europe Blood Transfusion Diagnostics Market - Prominent Companies
8.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
8.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
8.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
8.6 Europe Blood Transfusion Diagnostics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Blood Transfusion Diagnostics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Blood Transfusion Diagnostics Market : By Country
8.9 Germany Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.11 United Kingdom Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.13 France Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.14 France Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.15 Italy Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9. ASIA PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET : AN ANALYSIS (2016-2026)
9.1 Asia Pacific Blood Transfusion Diagnostics Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Blood Transfusion Diagnostics Market - Prominent Companies
9.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
9.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
9.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
9.6 Asia Pacific Blood Transfusion Diagnostics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Blood Transfusion Diagnostics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Blood Transfusion Diagnostics Market : By Country
9.9 China Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.10 China Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.11 Japan Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.13 India Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.14 India Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.15 South Korea Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Application Type, 2026
11.3 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. REGULATORY COMPLIANCE
14. COMPANY ANALYSIS
14.1 Abbott Laboratories
14.2 Bio-Rad Laboratories Inc.
14.3 F Hoffman-La Roche Ltd.
14.4 Market Attractiveness
14.5 Ortho Clinical Diagnostics
14.6 Danaher
14.7 Hologic Inc
14.8 Quest Diagnostics
14.9 Promega Corporation
14.10 Bio Kit
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. BLOOD TRANSFUSION DIAGNOSTICS MARKET: PRODUCT OUTLOOK
4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: SIZING AND FORECAST
4.1 Global Blood Transfusion Diagnostics Market Size, By Value, Year 2016-2026
5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION - BY PRODUCT, BY APPLICATION, BY END USER
5.1 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By Product
5.1.1 Kits & Reagents - Market Size and Forecast (2016-2026)
5.1.2 Instruments - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By Application Type
5.2.1 Disease Screening - Market Size and Forecast (2016-2026)
5.2.2 Blood Grouping - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Blood Transfusion Diagnostics Market: By End user
5.3.1 Hospitals - Market Size and Forecast (2016-2026)
5.3.2 Blood Banks - Market Size and Forecast (2016-2026)
5.3.3 Others - Market Size and Forecast (2016-2026)
6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Blood Transfusion Diagnostics Market : By Region
7. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET: AN ANALYSIS (2016-2026)
7.1 North America Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.2 North America Blood Transfusion Diagnostics Market - Prominent Companies
7.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
7.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
7.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
7.6 North America Blood Transfusion Diagnostics Market: Country Analysis
7.7 Market Opportunity Chart of North America Blood Transfusion Diagnostics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Blood Transfusion Diagnostics Market : By Country
7.9 United States Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.10 United States Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
7.11 Canada Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET : AN ANALYSIS (2016-2026)
8.1 Europe Blood Transfusion Diagnostics Market : Size and Forecast (2016-2026), By Value
8.2 Europe Blood Transfusion Diagnostics Market - Prominent Companies
8.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
8.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
8.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
8.6 Europe Blood Transfusion Diagnostics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Blood Transfusion Diagnostics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Blood Transfusion Diagnostics Market : By Country
8.9 Germany Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.11 United Kingdom Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.13 France Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.14 France Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
8.15 Italy Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9. ASIA PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET : AN ANALYSIS (2016-2026)
9.1 Asia Pacific Blood Transfusion Diagnostics Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Blood Transfusion Diagnostics Market - Prominent Companies
9.3 Market Segmentation By Product ( Kits & Reagents and Instruments)
9.4 Market Segmentation By Application (Disease Screening and Blood Grouping)
9.5 Market Segmentation By End User (Hospitals, Blood Banks and Others)
9.6 Asia Pacific Blood Transfusion Diagnostics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Blood Transfusion Diagnostics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Blood Transfusion Diagnostics Market : By Country
9.9 China Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.10 China Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.11 Japan Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.13 India Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.14 India Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
9.15 South Korea Blood Transfusion Diagnostics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Blood Transfusion Diagnostics Market Segmentation - By Product, By Application and By End User (2016-2026)
10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Application Type, 2026
11.3 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. REGULATORY COMPLIANCE
14. COMPANY ANALYSIS
14.1 Abbott Laboratories
14.2 Bio-Rad Laboratories Inc.
14.3 F Hoffman-La Roche Ltd.
14.4 Market Attractiveness
14.5 Ortho Clinical Diagnostics
14.6 Danaher
14.7 Hologic Inc
14.8 Quest Diagnostics
14.9 Promega Corporation
14.10 Bio Kit
LIST OF FIGURES
Figure 1: Global Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Expenses (% GDP), 2015-2019
Figure 6: GDP per Capita Growth (annual %), 2015-2019
Figure 7: World Population 65 Years & Above (% of Total), 2015-2019
Figure 8: Prevalence of Blood Disorder, by Type, Global, 2018
Figure 9: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 10: Global Blood Transfusion Diagnostics Market- By Product Market Share, 2020 & 2026
Figure 11: Global Blood Transfusion Diagnostics Market- By Kits & Reagents, By Value (USD Million), 2016-2026
Figure 12: Global Blood Transfusion Diagnostics Market- By Instruments, By Value (USD Million), 2016-2026
Figure 13: Global Blood Transfusion Diagnostics Market- By Application Market Share, 2020 & 2026
Figure 14: Global Blood Transfusion Diagnostics Market- By Disease Screening, By Value (USD Million), 2016-2026
Figure 15: Global Blood Transfusion Diagnostics Market- By Blood Grouping, By Value (USD Million), 2016-2026
Figure 16: Global Blood Transfusion Diagnostics Market- By End User Market Share, 2020 & 2026
Figure 17: Global Blood Transfusion Diagnostics Market- By Hospitals, By Value (USD Million), 2016-2026
Figure 18: Global Blood Transfusion Diagnostics Market- By Blood Bank, By Value (USD Million), 2016-2026
Figure 19: Global Blood Transfusion Diagnostics Market- By Others, By Value (USD Million), 2016-2026
Figure 20: Global Blood Transfusion Diagnostics Market- By Region Market Share, 2020 & 2026
Figure 21: North America Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 23: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 24: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 25: North America Urban population, 2015-2018 (In %)
Figure 26: North America Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 27: North America Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 28: North America Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 29: Market Opportunity Chart of North America Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 30: North America Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 31: United States Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 32: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 33: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 34: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 35: United States Urban population, 2016-2019 (In %)
Figure 36: United State Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 37: United State Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 38: United State Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 39: Canada Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 40: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 41: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 42: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 43: Canada Urban population, 2015-2019 (In %)
Figure 44: Canada Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 45: Canada Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 46: Canada Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 47: Europe Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 48: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 49: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 50: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 51: Europe Urban population, 2015-2019 (In %)
Figure 52: Europe Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 53: Europe Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 54: Europe Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 55: Market Opportunity Chart of Europe Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 56: Europe Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 57: Germany Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 58: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 59: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 60: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 61: Germany Urban population, 2015-2019 (In %)
Figure 62: Germany Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 63: Germany Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 64: Germany Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 65: United Kingdom Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 66: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 67: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 68: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 69: United Kingdom Urban population, 2015-2019 (In %)
Figure 70: United Kingdom Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 71: United Kingdom Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 72: United Kingdom Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 73: France Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 74: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 75: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 76: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 77: France Urban population, 2015-2019 (In %)
Figure 78: France Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 79: France Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 80: France Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 81: Italy Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 82: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 83: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 84: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 85: Italy Urban population, 2015-2019 (In %)
Figure 86: Italy Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 87: Italy Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 88: Italy Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 89: Asia Pacific Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 90: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 91: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 92: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 93: Asia Pacific Urban population, 2015-2019 (In %)
Figure 94: Asia Pacific Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 95: Asia Pacific Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 96: Asia Pacific Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 97: Market Opportunity Chart of APAC Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 98: APAC Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 99: China Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 100: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 101: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 102: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 103: China Urban Population (%) of total population, 2016-2020
Figure 104: China Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 105: China Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 106: China Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 107: Japan Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 108: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 109: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 110: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 111: Japan Urban Population (%) of total population, 2016-2020
Figure 112: Japan Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 113: Japan Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 114: Japan Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 115: India Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 116: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 117: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 118: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 119: India Urban Population (%) of total population, 2016-2020
Figure 120: India Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 121: India Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 122: India Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 123: South Korea Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 124: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 125: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 126: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 127: South Korea Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 128: South Korea Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 129: South Korea Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 130: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Product (Year-2026)
Figure 131: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Application (Year-2026)
Figure 132: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By End User (Year-2026)
Figure 133: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Region (Year-2026)
Figure 134: Global Blood Transfusion Diagnostics company market share (%), 2019
Figure 135: Abbott Laboratories Sales Revenues, 2016-2020 (USD Million)
Figure 136: Abbott Laboratories Net Earnings, 2016-2020 (USD Million)
Figure 137: Abbott Laboratories sales Revenues, By Business Segment (%), FY2020
Figure 138: Abbott Laboratories sales Revenue, By Geographical Segment (%), FY2020
Figure 139: Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
Figure 140: Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
Figure 141: Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
Figure 142: Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
Figure 143: F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
Figure 144: F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
Figure 145: F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
Figure 146: F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
Figure 147: Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 148: Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Figure 149: Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Figure 150: Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 151: Ortho Clinical Diagnostics Sales Revenues, 2016-2020 (USD Million)
Figure 152: Ortho Clinical Diagnostics Gross Profit, 2016-2020 (USD Million)
Figure 153: Ortho Clinical Diagnostics sales Revenues, By Business Segment (%), FY2020
Figure 154: Ortho Clinical Diagnostics sales Revenue, By Geographical Segment (%), FY2020
Figure 155: Danaher Sales Revenues, 2016-2020 (USD Million)
Figure 156: Danaher Gross Profit, 2016-2020 (USD Million)
Figure 157: Danaher sales Revenues, By Business Segment (%), FY2020
Figure 158: Danaher sales Revenue, By Geographical Segment (%), FY2020
Figure 159: Hologic Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 160: Hologic Inc. Net Income, 2016-2020 (USD Million)
Figure 161: Hologic Inc. sales Revenues, By Business Segment (%), FY2020
Figure 162: Hologic Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 163: Quest Diagnostics Sales Revenues, 2015-2019 (USD Million)
Figure 164: Quest Diagnostics Net Income, 2015-2019 (USD Million)
Figure 1: Global Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Expenses (% GDP), 2015-2019
Figure 6: GDP per Capita Growth (annual %), 2015-2019
Figure 7: World Population 65 Years & Above (% of Total), 2015-2019
Figure 8: Prevalence of Blood Disorder, by Type, Global, 2018
Figure 9: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 10: Global Blood Transfusion Diagnostics Market- By Product Market Share, 2020 & 2026
Figure 11: Global Blood Transfusion Diagnostics Market- By Kits & Reagents, By Value (USD Million), 2016-2026
Figure 12: Global Blood Transfusion Diagnostics Market- By Instruments, By Value (USD Million), 2016-2026
Figure 13: Global Blood Transfusion Diagnostics Market- By Application Market Share, 2020 & 2026
Figure 14: Global Blood Transfusion Diagnostics Market- By Disease Screening, By Value (USD Million), 2016-2026
Figure 15: Global Blood Transfusion Diagnostics Market- By Blood Grouping, By Value (USD Million), 2016-2026
Figure 16: Global Blood Transfusion Diagnostics Market- By End User Market Share, 2020 & 2026
Figure 17: Global Blood Transfusion Diagnostics Market- By Hospitals, By Value (USD Million), 2016-2026
Figure 18: Global Blood Transfusion Diagnostics Market- By Blood Bank, By Value (USD Million), 2016-2026
Figure 19: Global Blood Transfusion Diagnostics Market- By Others, By Value (USD Million), 2016-2026
Figure 20: Global Blood Transfusion Diagnostics Market- By Region Market Share, 2020 & 2026
Figure 21: North America Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 23: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 24: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 25: North America Urban population, 2015-2018 (In %)
Figure 26: North America Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 27: North America Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 28: North America Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 29: Market Opportunity Chart of North America Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 30: North America Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 31: United States Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 32: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 33: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 34: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 35: United States Urban population, 2016-2019 (In %)
Figure 36: United State Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 37: United State Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 38: United State Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 39: Canada Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 40: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 41: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 42: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 43: Canada Urban population, 2015-2019 (In %)
Figure 44: Canada Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 45: Canada Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 46: Canada Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 47: Europe Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 48: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 49: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 50: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 51: Europe Urban population, 2015-2019 (In %)
Figure 52: Europe Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 53: Europe Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 54: Europe Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 55: Market Opportunity Chart of Europe Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 56: Europe Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 57: Germany Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 58: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 59: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 60: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 61: Germany Urban population, 2015-2019 (In %)
Figure 62: Germany Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 63: Germany Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 64: Germany Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 65: United Kingdom Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 66: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 67: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 68: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 69: United Kingdom Urban population, 2015-2019 (In %)
Figure 70: United Kingdom Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 71: United Kingdom Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 72: United Kingdom Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 73: France Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 74: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 75: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 76: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 77: France Urban population, 2015-2019 (In %)
Figure 78: France Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 79: France Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 80: France Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 81: Italy Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 82: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 83: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 84: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 85: Italy Urban population, 2015-2019 (In %)
Figure 86: Italy Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 87: Italy Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 88: Italy Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 89: Asia Pacific Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 90: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 91: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 92: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 93: Asia Pacific Urban population, 2015-2019 (In %)
Figure 94: Asia Pacific Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 95: Asia Pacific Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 96: Asia Pacific Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 97: Market Opportunity Chart of APAC Blood Transfusion Diagnostics Market- By Country, By Value (Year-2026)
Figure 98: APAC Blood Transfusion Diagnostics Market- By Country Market Share, 2020 & 2026
Figure 99: China Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 100: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 101: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 102: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 103: China Urban Population (%) of total population, 2016-2020
Figure 104: China Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 105: China Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 106: China Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 107: Japan Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 108: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 109: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 110: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 111: Japan Urban Population (%) of total population, 2016-2020
Figure 112: Japan Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 113: Japan Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 114: Japan Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 115: India Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 116: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 117: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 118: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 119: India Urban Population (%) of total population, 2016-2020
Figure 120: India Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 121: India Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 122: India Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 123: South Korea Blood Transfusion Diagnostics Market Size, By Value, 2016-2026 (USD Million)
Figure 124: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 125: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 126: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 127: South Korea Blood Transfusion Diagnostics Market- By Product, By Value (USD Million), 2016-2026
Figure 128: South Korea Blood Transfusion Diagnostics Market- By Application, By Value (USD Million), 2016-2026
Figure 129: South Korea Blood Transfusion Diagnostics Market- By End Users, By Value (USD Million), 2016-2026
Figure 130: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Product (Year-2026)
Figure 131: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Application (Year-2026)
Figure 132: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By End User (Year-2026)
Figure 133: Market Attractiveness Chart of Global Blood Transfusion Diagnostics Market- By Region (Year-2026)
Figure 134: Global Blood Transfusion Diagnostics company market share (%), 2019
Figure 135: Abbott Laboratories Sales Revenues, 2016-2020 (USD Million)
Figure 136: Abbott Laboratories Net Earnings, 2016-2020 (USD Million)
Figure 137: Abbott Laboratories sales Revenues, By Business Segment (%), FY2020
Figure 138: Abbott Laboratories sales Revenue, By Geographical Segment (%), FY2020
Figure 139: Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
Figure 140: Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
Figure 141: Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
Figure 142: Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
Figure 143: F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
Figure 144: F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
Figure 145: F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
Figure 146: F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
Figure 147: Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 148: Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Figure 149: Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Figure 150: Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 151: Ortho Clinical Diagnostics Sales Revenues, 2016-2020 (USD Million)
Figure 152: Ortho Clinical Diagnostics Gross Profit, 2016-2020 (USD Million)
Figure 153: Ortho Clinical Diagnostics sales Revenues, By Business Segment (%), FY2020
Figure 154: Ortho Clinical Diagnostics sales Revenue, By Geographical Segment (%), FY2020
Figure 155: Danaher Sales Revenues, 2016-2020 (USD Million)
Figure 156: Danaher Gross Profit, 2016-2020 (USD Million)
Figure 157: Danaher sales Revenues, By Business Segment (%), FY2020
Figure 158: Danaher sales Revenue, By Geographical Segment (%), FY2020
Figure 159: Hologic Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 160: Hologic Inc. Net Income, 2016-2020 (USD Million)
Figure 161: Hologic Inc. sales Revenues, By Business Segment (%), FY2020
Figure 162: Hologic Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 163: Quest Diagnostics Sales Revenues, 2015-2019 (USD Million)
Figure 164: Quest Diagnostics Net Income, 2015-2019 (USD Million)
